Assessment of management of cardiovascular risk factors in patients with thoracic aortic disease

Blood Pressure Monitoring

Volumn 17, Issue 6, 2012, Pages 235-242

  Bastien, Marjorie ^a,c   Dagenais, François ^a,b   Dumont, Éric ^a,b   Vadeboncoeur, Nathalie ^a,c   Dion, Brigitte ^a   Royer, Maryse ^a   Gaudet Savard, Thierry ^a,b   Poirier, Paul ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Faculty of Pharmacy   (Canada)

Author keywords

cardiovascular risk factors; hypertension and adiposity; thoracic aortic disease

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN INHIBITOR; TRIACYLGLYCEROL;

AGED; ANTHROPOMETRY; AORTA DISEASE; AORTA DISSECTION; AORTA RUPTURE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HEART REHABILITATION; HEMATOMA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK MANAGEMENT; THORACIC AORTA; THORACIC AORTA ANEURYSM; ULCER; WAIST CIRCUMFERENCE;

AGED; ANTHROPOMETRY; AORTA; AORTIC DISEASES; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84870257181     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0b013e32835b9e74     Document Type: Article

References (46)

1. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr., et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121:e266-e369.
2. Johansson G, Markstrom U, Swedenborg J. Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg 1995; 21:985-988.
3. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000; 283:897-903. (Pubitemid 30102130)
4. Olsson C, Thelin S, Stahle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14 000 cases from 1987 to 2002. Circulation 2006; 114:2611-2618. (Pubitemid 44967344)
5. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation 1995; 91:734-740.
6. Elefteriades AJ, Olin JW, Halperin JL. Chapter 105: diseases of the aorta. In: Valentin F, Robert AOR, Richard AW, Philip P-W, editors. Hurst's the heart. China: The McGraw-Hill Companies; 2009.
7. Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation 2005; 111:816-828. (Pubitemid 40250643)
8. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994; 330:1335-1341.
9. Ahimastos AA, Aggarwal A, D'Orsa KM, Formosa MF,White AJ, Savarirayan R, et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 2007; 298:1539-1547. (Pubitemid 47529388)
10. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC III. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 2008; 358:2787-2795. (Pubitemid 351930853)
11. Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, Dunkelgrun M, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006; 32:21-26. (Pubitemid 43842752)
12. Ferguson CD, Clancy P, Bourke B, Walker PJ, Dear A, Buckenham T, et al. Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J 2010; 159:307-313.
13. Ito S, Akutsu K, Tamori Y, Sakamoto S, Yoshimuta T, Hashimoto H, et al. Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol 2008; 101:696-699. (Pubitemid 351625099)
14. Yetman AT, McCrindle BW. The prevalence and clinical impact of obesity in adults with Marfan syndrome. Can J Cardiol 2010; 26: 137-139.
15. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult- 2009 recommendations. Can J Cardiol 2009; 25:567-579.
16. Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity? Eur Heart J 2007; 28:2047-2048. (Pubitemid 47517455)
17. Bertrand OF, Poirier P, Rodes-Cabau J, Rinfret S, Title L, Dzavik V, et al. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. Can J Cardiol 2009; 25: 509-515.
18. National Institutes of Health. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health; 2000; p. 80.
19. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000; 72:694-701. (Pubitemid 30667089)
20. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Belgium: International Diabetes Federation; 2009; p. 16.
21. Quinn RR, Hemmelgarn BR, Padwal RS, Myers MG, Cloutier L, Bolli P, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2010; 26: 241-248.
22. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536.
23. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005; 2:e160.
24. Hatzaras IS, Bible JE, Koullias GJ, Tranquilli M, Singh M, Elefteriades JA. Role of exertion or emotion as inciting events for acute aortic dissection. Am J Cardiol 2007; 100:1470-1472. (Pubitemid 47576027)
25. Nesi G, Anichini C, Tozzini S, Boddi V, Calamai G, Gori F. Pathology of the thoracic aorta: a morphologic review of 338 surgical specimens over a 7-year period. Cardiovasc Pathol 2009; 18:134-139.
26. He R, Guo DC, Estrera AL, Safi HJ, Huynh TT, Yin Z, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg 2006; 131:671-678.
27. He R, Guo DC, Sun W, Papke CL, Duraisamy S, Estrera AL, et al. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg 2008; 136:922-929, e921.
28. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808. (Pubitemid 38063703)
29. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19:972-978. (Pubitemid 29177345)
30. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994; 331:468-469. (Pubitemid 24247405)
31. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009; 53:577-584.
32. Public Health Agency of Canada, Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada, 2010. Available at: http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/index-fra.php [Accessed 6 November 2012].
33. Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al. Assessing adiposity: a scientific statement from the american heart association. Circulation 2011; 124:1996-2019.
34. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359:2105-2120.
35. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189. (Pubitemid 35388236)
36. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370:1219-1229. (Pubitemid 47503300)
37. Iwata S, Jin Z, Schwartz JE, Homma S, Elkind MS, Rundek T, et al. Relationship between ambulatory blood pressure and aortic arch atherosclerosis. Atherosclerosis 2012; 221:427-431.
38. Guo DC, Papke CL, He R, Milewicz DM. Pathogenesis of thoracic and abdominal aortic aneurysms. Ann NY Acad Sci 2006; 1085:339-352. (Pubitemid 47091985)
39. Baguet JP, Minville C,Tamisier R, Roche F, Barone-Rochette G, Ormezzano O, et al. Increased aortic root size is associated with nocturnal hypoxia and diastolic blood pressure in obstructive sleep apnea. Sleep 2011; 34: 1605-1607.
40. Lee LC, Torres MC, Khoo SM, Chong EY, Lau C, Than Y, et al. The relative impact of obstructive sleep apnea and hypertension on the structural and functional changes of the thoracic aorta. Sleep 2010; 33:1173-1176.
41. National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. London: National Institute for Health and Clinical Excellence; 2011.
42. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am Heart J 2008; 156:528-536, e521-e525.
43. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22:554-572.
44. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D, et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 2005; 241:92-101. (Pubitemid 40040997)
45. Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A. Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes 2002; 51:3063-3068.
46. Bonser RS, Pagano D, Lewis ME, Rooney SJ, Guest P, Davies P, et al. Clinical and patho-anatomical factors affecting expansion of thoracic aortic aneurysms. Heart 2000; 84:277-283.